Program
Notes:
- All session times for the AACR Virtual Conference on The Science of Cancer Health Disparities are U.S. Eastern Daylight Time (EDT).
- Poster presentations will be available throughout the meeting as an on-demand session beginning at 9:30 a.m. EDT on Friday, October 2.
Friday, October 2, 2020
- Opening Session
- Concurrent Session 1: Progress in Impact of Diversity and Inclusion in Clinical Trials
- Concurrent Session 2: Health Care Policy in Advancing Cancer Health Equity
- Concurrent Session 3: Disparities in Cancer Risk and Treatment among the LGBTQ Population
- Concurrent Session 4: From Bench to Bedside to Community: Using Race/Ethnic-Appropriate Models in Precision Medicine
- Concurrent Hot Topics in Cancer Health Disparities 1
- Concurrent Hot Topics in Cancer Health Disparities 2
Saturday, October 3, 2020
- Plenary Session 1: Trans-disciplinary Convergence Approaches to Cancer Health Disparities Research
- Concurrent Session 5: Prevention, Screening, and Surveillance in the Adolescent Young Adult Cancer Population
- Concurrent Session 6: Biology of Cancer Disparities and Potential Impact on Precision Oncology in Diverse Populations
- Concurrent Session 7: Cancer Clinical Trial Inclusion and Diversity- Challenges and Opportunities
- Concurrent Session 8: Addressing Disparities in Survivorship- Supportive, Palliative, and End-of-Life Care
- Concurrent Hot Topics in Cancer Health Disparities 3
- Concurrent Hot Topics in Cancer Health Disparities 4
Sunday, October 4, 2020
- Concurrent Session 9: Understanding the Role of Cancer Immunology and the Tumor Microenvironment in Cancer Health Disparities
- Concurrent Session 10: Opportunities and Challenges in Global Cancer Disparities Research
- Concurrent Session 11: Advanced Molecular Technologies in Cancer Disparities Discovery Research
- Concurrent Session 12: Disparities in Cancer Outcomes: Biology, Access, and Equity
- Plenary Session 2: Innovation in Growing a Diverse Workforce in Cancer Research
- Closing Remarks
Friday, October 2
Opening Session
10 a.m.-12 p.m.
CHANNEL 1
Welcome Remarks
Advocate Video
Minorities in Cancer Research 20th Anniversary
John D. Carpten, Keck School of Medicine of University of Southern California, Los Angeles, California
Distinguished Lecture Series
Optimizing engagement to reduce disparities among Hispanic/Latinos/Latinx and other underserved communities
Lourdes Baezconde-Garbanati, Keck School of Medicine of University of Southern California, Los Angeles, California
Keynote Address
Title to be announced
Francis S. Collins, Director of the National Institutes of Health, Bethesda, Maryland
Opening Session Panel
Moderator: Robert Winn, VCU Massey Cancer Center, Richmond, Virginia
Panelists:
Patricia LoRusso, Yale School of Medicine, New Haven, Connecticut
Clayton Yates, Tuskegee University, Tuskegee, Alabama
Chanita Hughes-Halbert, MUSC Hollings Cancer Center, Charleston, South Carolina
Brian Rivers, Morehouse School of Medicine, Atlanta, Georgia
Mariana Stern, Keck School of Medicine of University of Southern California, Los Angeles, California
Break
12-12:15 p.m.
Concurrent Session 1: Progress in Impact of Diversity and Inclusion in Clinical Trials
Session Cochairs: Worta McCaskill-Stevens, National Cancer Institute,
Bethesda, Maryland; Martin Mendoza, Office of Minority Health, Rockville, Maryland
12:15-1:45 p.m.
CHANNEL 1
Clinical trial diversity: A perspective from the FDA Office of Minority Health and Health Equity
Rear Admiral Richardae Araojo, U.S. Food and Drug Administration, Associate Commissioner for Minority Health, Silver Spring, Maryland
Diversity in clinical research participation an equity imperative
Nadine J. Barrett, Duke Cancer Institute, Durham, North Carolina
Achieving diversity and inclusion in clinical research: Critical role of community partnerships and collaborations
Luther T. Clark, Merck & Co., Rahway, New Jersey
How a person can use their privilege to help end disparities
Julia Maues, GRASP Cancer, Washington, D.C.
Addressing racial health care disparities by advancing inclusive research
Melissa S. Gonzales, Genentech, South San Francisco, California
(Not eligible for CME credit)
Concurrent Session 2: Health Care Policy in Advancing Cancer Health Equity
Session Cochairs: Brian M. Rivers, Morehouse School of Medicine, Atlanta, Georgia; Karen M. Winkfield, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
12:15 p.m.- 1:45 p.m.
CHANNEL 2
Congressional perspective on addressing cancer health disparities
Raul Ruiz, U.S. Representative, California’s 36th District
Re-examining the interplay between structure, cancer, and cancer health policy
Robert A. Winn, VCU Massey Cancer Center, Richmond, Virginia
Racial and ethnic underrepresentation in clinical trials: Immediate action is an imperative
Lola Fashoyin-Aje, Food and Drug Administration, Silver Spring, Maryland
How patient advocates can advance cancer health equity: Tales from the frontlines
Lisa Laudico, SHARE Cancer Support: Our MBC Life Podcast, Westport, Connecticut
Break
1:45-2 p.m.
Concurrent Session 3: Disparities in Cancer Risk and Treatment among the LGBTQ Population
Session Cochairs: Jesse Ehrenfeld, Vanderbilt University, Nashville, Tennessee; Matthew R. Schabath, Moffitt Cancer Center, Tampa, Florida
2-3:30 p.m.
CHANNEL 1
The Prevent Anal Cancer Study: The assessment of novel opportunities for anal cancer screening during COVID-19
Alan Nyitray, Medical College of Wisconsin, Milwaukee, Wisconsin
Improving cultural humility training for oncology clinicians
Gwendolyn P. Quinn, New York University Langone Medical Center, New York, New York
Cancer in LGBT populations: Differences, disparities, and strategies for change
Kellen Baker, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Concurrent Session 4: From Bench to Bedside to Community: Using Race/Ethnic-Appropriate Models in Precision Medicine
Session Chair: Luis Carvajal-Carmona, University of California Davis, Davis, California
2-3:30 p.m.
CHANNEL 2
Engaging all patients in translational research
Bodour Salhia, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California
Advancing gastric cancer precision medicine through minority patient-derived modeling
Luis Carvajal-Carmona
Development of novel models and identification of therapeutic vulnerabilities in highly aggressive prostate cancer In African American men
Salma Kaochar, Baylor College of Medicine, Houston, Texas
Break
3:30-3:45 p.m.
Concurrent Hot Topics in Cancer Health Disparities 1
Session Chair: Gerardo Colón-Otero, Mayo Clinic Cancer Center, Jacksonville, Florida
3:45-5 p.m.
CHANNEL 1
Breast cancer in Ghana: A study of the characteristics of breast cancers
reported nationally from 2018 to 2020*
Kafui Akakpo, Pathologist Without Borders, Accra, Ghana
Improving monitoring and treatment adherence among underserved Asian Americans with chronic hepatitis B through a patient navigator-led intervention*
Grace Ma, Center for Asian Health, Temple University, Philadelphia, Pennsylvania
Racial and health care access disparities in palliative care receipt among patients with advanced non-small cell lung cancer: An analysis of the 2016 National Cancer Database*
Jessica Islam, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Low-income minorities and immigrants are priority targets in late-stage
hepatocellular carcinoma hotspots*
Kali Zhou, University of Southern California, Los Angeles, California
Epigenetic disruption of vitamin D receptor signaling in African American prostate cancer alters circadian signaling networks*
Moray Campbell, The Ohio State University, Columbus, Ohio
Concurrent Hot Topics in Cancer Health Disparities 2
Session Chair: Lisa A. Newman, Weill Cornell Medicine, New York, New York
3:45-5 p.m.
CHANNEL 2
Different places, same problems: Tales of Deep South and Midwestern young
African American breast cancer survivorship care*
Timiya Nolan, The Ohio State University, Columbus, Ohio
Impact of race on the uterine microbiome in women with early-stage endometrial cancer*
Gabrielle Hawkins, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
African-centric p53 hypomorphs play significant roles in cancer risk and efficacy of therapy*
Maureen Murphy, The Wistar Institute, Philadelphia, Pennsylvania
HT Helper: mHealth app to promote hormone therapy adherence among breast cancer patients*
Patricia Chalela, UT Health San Antonio, San Antonio, Texas
Multi-omic disparities in head and neck squamous cell carcinomas in patients of different racio-ethnic backgrounds*
Hugh J. Kim, Western University, London, Ontario, Canada
Saturday, October 3
Plenary Session 1: Trans-disciplinary Convergence Approaches to Cancer Health Disparities Research
Session Cochairs: Chanita Hughes-Halbert, MUSC Hollings Cancer Center, Charleston, South Carolina; Robert A. Winn, Virginia Commonwealth University, Richmond, Virginia
10-11:30 a.m.
CHANNEL 1
Lung cancer risk assessment in diverse populations: One size cannot fit all
Patrick Nana-Sinkam, Virginia Commonwealth University, Richmond, Virginia
Lung cancer screening: A public health benefit that may deepen the divide
Nichole T. Tanner, Medical University of South Carolina, Charleston, South Carolina
Hard truths on the road to knowledge: The challenges and triumphs of transdisciplinary health equity research
Christopher Lathan, Dana-Farber Cancer Institute, Boston, Massachusetts
Break
11:30-11:45 a.m.
Concurrent Session 5: Prevention, Screening, and Surveillance in the Adolescent Young Adult Cancer Population
Session Cochairs: Kimberly J. Johnson, Washington University in St. Louis, St. Louis, Missouri; Jun J. Yang, St. Jude Children’s Research Hospital, Memphis, Tennessee
11:45 a.m.-1:15 p.m.
CHANNEL 1
Genetic risk for subsequent breast cancer among female survivors of childhood cancer
Zhaoming Wang, St. Jude Children’s Research Hospital, Memphis, Tennessee
Second cancers and survival in adolescent and young adult cancer survivors
Theresa Keegan, University of California Davis, Davis, California
Addressing gaps in health insurance literacy among adolescent and young adult cancer patients
Anne Kirchhoff, Huntsman Cancer Institute, Salt Lake City, Utah
Understanding causes of inferior survival in adolescent and young adults with acute lymphoblastic leukemia
Smita Bhatia, University of Alabama at Birmingham, Birmingham, Alabama
Concurrent Session 6: Biology of Cancer Disparities and Potential Impact on Precision Oncology in Diverse Populations
Session Cochairs: Camille Ragin, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Clayton C. Yates, Tuskegee University, Tuskegee, Alabama
11:45 a.m.- 1:15 p.m.
CHANNEL 2
Cadmium exposure, DNA methylation, and liver cancer
Catherine Hoyo, North Carolina State University, Raleigh, North Carolina
Biology of aggressive breast cancer in women of African descent
Tomi Akinyemiju, Duke University School of Medicine, Durham, North Carolina
Black Lives Matter worldwide: Retooling precision oncology for true equity of cancer care
Olufunmilayo I. Olopade, University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Break
1:15-1:30 p.m.
Concurrent Session 7: Cancer Clinical Trial Inclusion and Diversity: Challenges and Opportunities
Session Cochairs: Windy Dean-Colomb, Our Lady of Lourdes JD Moncus Cancer Center, Lafayette, Louisiana; Lewis R. Roberts, Mayo Clinic, Rochester, Minnesota
1:30 p.m.- 3 p.m.
CHANNEL 1
Learning from and addressing racial and ethnic disparities in cancer clinical trials: The ECOG-ACRIN experience
Joseph A. Sparano, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York
A survivor perspective: The imperative to act on what we know
Dicey Scroggins, International Gynecologic Cancer Society, Pinkie Huggs, LLC, Washington, D.C.
Addressing cancer disparity from a global perspective: Increasing participation of African descendants in trans-national clinical trials
Windy Dean-Colomb
Concurrent Session 8: Addressing Disparities in Survivorship- Supportive, Palliative, and End-of-Life Care
Session Cochairs: Kimlin T. Ashing, City of Hope, Duarte, California; Diana J. Wilkie, University of Florida, Gainesville, Florida
1:30-3 p.m.
CHANNEL 2
Structural inequities, social determinants, and survivorship: Opportunities and strategies to advance health equity
Kassandra I. Alcaraz, Georgia State University School of Public Health, Atlanta, Georgia
Addressing psychosocial health disparities among Latina breast cancer survivors
Anna Napoles, National Institute on Minority Health and Health Disparities, Bethesda, Maryland
Effects of a pandemic on end-of-life decision making in African Americans
Tammie Quest, Winship Cancer Institute of Emory University, Atlanta, Georgia
African Americans disparities in palliative and end-of-life care
Rhonda Smith, California Black Health Network, Los Angeles, California
Break
3-3:15 p.m.
Concurrent Hot Topics in Cancer Health Disparities 3
Session Chair: John D. Carpten, Keck School of Medicine of University of Southern California, Los Angeles, California
3:15-4:30 p.m.
CHANNEL 1
Cause-and-effect relationships between glycation and the ancestry-specific tumor stroma*
Courtney Lloyd, Medical University of South Carolina, Charleston, South Carolina
Dynamic clustering of cancer genomics datasets beyond pre-defined human categories*
Hussein Mohsen, Yale University, New Haven, Connecticut
Multilevel pathways of colorectal cancer screening among low-income Vietnamese Americans: A structural equation modeling analysis*
Grace Ma, Center for Asian Health, Temple University, Philadelphia, Pennsylvania
Mutational landscape of diffuse large B-cell lymphoma in patients with genome-defined African ancestry*
Michelle Lee, Morehouse School of Medicine, Atlanta, Georgia
CanSplice: A user-friendly web application for analysis of genomic datasets by race and ethnicity*
Muthana Al Abo, Duke Cancer Institute, Durham, North Carolina
Concurrent Hot Topics in Cancer Health Disparities 4
Session Chair: Marcia Cruz-Correa, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
3:15-4:30 p.m.
CHANNEL 2
All-cause and cause-specific mortality among Medicaid-insured women with preexisting type 2 diabetes diagnosed with breast cancer: A cancer registry-Medicaid linkage*
Wayne Lawrence, National Cancer Institute, Rockville, Maryland
Metabolic rewiring in African-American prostate cancer: A role of adenosine-inosine axis*
Christy Charles, Baylor College of Medicine, Houston, Texas
The immune landscape of prostate cancer in African American patients is skewed towards inhibitory signatures relative to Caucasian American patients*
Dennis Adeegbe, Moffitt Cancer Center, Tampa, Florida
Interrogating the molecular profile of solid tumors in Puerto Rican Hispanics: Defining actionable mutations and drivers of carcinogenesis*
Camila Rivera Lynch, University of Puerto Rico School of Medicine School of Medicine, San Juan, Puerto Rico
Work outcomes, financial distress, and health-related quality of life among African American cancer survivors*
Theresa Hastert, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Minorities in Cancer Research Professional Advancement Session
Zoom Webinar
5:30-7 p.m.
Information to be announced
Sunday, October 4
Concurrent Session 9: Understanding the Role of Cancer Immunology and the Tumor Microenvironment in Cancer Health Disparities
Session Cochairs: Melissa B. Davis, Weill Cornell, New York, New York; Luis A. Diaz, Memorial Sloan Kettering Cancer Center, New York, New York
10-11:30 a.m.
CHANNEL 1
The immunogenomic landscape of primary prostate cancer in African American men
Tamara Lotan, Johns Hopkins University, Baltimore, Maryland
Distinct heterogeneous subtypes of triple-negative breast cancer associated with African ancestry
Melissa B. Davis
Novel biological insights into colorectal cancer from West Africa
T. Peter Kingham, Memorial Sloan Kettering Cancer Center, New York, New York
Concurrent Session 10: Opportunities and Challenges in Global Cancer Disparities Research
Session Cochairs: Folakemi T. Odedina, University of Florida, Orlando, Florida; Gilberto de Lima Lopes, University of Miami, Miami, Florida
10-11:30 a.m.
CHANNEL 2
Cancer disparity in Sub-Saharan Africa: Challenges and opportunities
Abubakar Bello, National Hospital, Abuja, Nigeria
Disparities in cancer clinical trials: The Caribbean perspective
Gilian Wharfe, University of the West Indies at Mona, Kingston, Jamaica
A perspective on global cancer disparities from the NCI Center for Global Health
Satish Gopal, Center for Global Health, National Cancer Institute, Bethesda, Maryland
Discrepancies in accessing clinical trials in Africa
Delva Shamley, University of Cape Town, Cape Town, South Africa
Break
11:30-11:45 a.m.
Concurrent Session 11: Advanced Molecular Technologies in Cancer Disparities Discovery Research
Session Cochairs: John D. Carpten, Keck School of Medicine of University of Southern California, Los Angeles, California; Jelani C. Zarif, Johns Hopkins School of Medicine, Baltimore, Maryland
11:45 a.m.-1:15 p.m.
CHANNEL 1
Single-cell comparative biology of human and mouse prostate cancer
Vasan Yegnasubramanian, Johns Hopkins School of Medicine, Baltimore, Maryland
Novel approaches for assessing molecular heterogeneity in cancer
Lee Gibbs, Keck School of Medicine of University of Southern California, Los Angeles, California
Advances in molecular characterization of multiple myeloma and its precursor states
Mark W. Bustoros, Dana-Farber Cancer Institute, Boston, Massachusetts
Concurrent Session 12: Disparities in Cancer Outcomes: Biology, Access, and Equity
Session Chair: Timothy R. Rebbeck, Dana-Farber Cancer Institute, Boston, Massachusetts
11:45 a.m.-1:15 p.m.
CHANNEL 2
Biological and social influences on disparities in prostate cancer mortality
Timothy R. Rebbeck
Equity and access: Looking upstream to make lasting improvements in cancer outcomes
Sandi L. Pruitt, UT Southwestern Medical Center, Dallas, Texas
Genomics contributors to tumor subtypes in African American prostate and breast cancer patients
Clayton C. Yates, Tuskegee University, Tuskegee, Alabama
Break
1:15-1:30 p.m.
Plenary Session 2: Innovation in Growing a Diverse Workforce in Cancer Research
Session Cochairs: Sanya A. Springfield, National Cancer Institute, Bethesda, Maryland; Alison Lin, National Cancer Institute, Bethesda, Maryland
1:30-3 p.m.
CHANNEL 1
Overcoming barriers and defining success: Diversity inclusion and belonging in the healthcare workforce
Joan Y. Reede, Harvard Medical School, Boston, Massachusetts
Alden Landry, Harvard Medical School, Boston, Massachusetts
Engagement with Native American communicites
Maurice Godfrey, University of Nebraska Medical Center, Omaha, Nebraska
New perspectives on training complex communication
Frederick Kron, University of Michigan Medical School, Ann Arbor, Michigan
Minorities in Cancer Health Disparities Town Hall
3:15-5:15 p.m.
Zoom Webinar
Information to be announced
*Short talk from proffered abstract